Statins decrease insulin resistance by selectively inhibiting the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase and downregulating the mevalonate pathway, which is closely associated with insulin resistance [189]. The gene discussed is HMGCR; the disease is Insulin resistance.